Corcept Therapeutics
Yahoo Finance • 4 days ago
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Corcept (NASDAQ:CORT)
Reflecting On Branded Pharmaceuticals Stocks' Q2 Earnings: Corcept (NASDAQ:CORT) Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at Corcept (NASDAQ:CORT) and its... Full story
Yahoo Finance • 5 days ago
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?
The State Street SPDR S&P Biotech ETF (NYSEMKT:XBI) provides broad exposure to the biotech industry, while the First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) offers a much more concentrated, equal-weighted alternative. Biote... Full story
Yahoo Finance • 10 days ago
Notable ETF Outflow Detected - SPSM, CORT, GKOS, EAT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Portfolio S&P 600 Small Cap ETF (Symbol: SPSM) where we have detected an approximate $125.1 million doll... Full story
Yahoo Finance • 14 days ago
High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
[Heart Health Concept] Eoneren/E+ via Getty Images Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price veloci... Full story
Yahoo Finance • 25 days ago
Stocks Settle Sharply Higher as Microsoft Leads a Surge in Tech Stocks
The S&P 500 Index ($SPX) (SPY) on Thursday closed up +1.66%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +1.19%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +3.36%. September E-mini S&P futures (ESU26) rose +1.65%, and S... Full story
Yahoo Finance • 25 days ago
Stocks Rally on Stellar Microsoft Earnings and Chip Stock Strength
The S&P 500 Index ($SPX) (SPY) today is up +0.86%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +2.65%. September E-mini S&P futures (ESU26) are up +0.84%, and September E-mini... Full story
Yahoo Finance • 30 days ago
How Do the Vanguard S&P 500 Growth ETF and the State Street Small Cap Growth ETF Compare?
The choice between Vanguard S&P 500 Growth ETF (NYSEMKT:VOOG) and State Street SPDR S&P 600 Small Cap Growth ETF (NYSEMKT:SLYG) hinges on whether an investor prefers large-cap stability and tech dominance or the potential higher volatility... Full story
Yahoo Finance • last month
Corcept Therapeutics (CORT) Is Up 5.3% After Analysts Lift Full-Year Earnings Outlook Significantly
Recently, Corcept Therapeutics received an upgraded Zacks Rank of #2 (Buy) after analysts sharply raised their full-year earnings estimates, reflecting a much stronger profit outlook than previously expected. This improved earnings view ha... Full story
Yahoo Finance • last month
Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?
Investors choosing between the State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) and First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) must weigh XLV's broad healthcare diversification and low cost against FBT's conc... Full story
Yahoo Finance • last month
Corcept's CFO Set His Selling Plan the Month the Stock Fell 50% — Here's What Investors Should Know
Key Points The transaction involved 40,000 shares with an estimated value of $3.5 million on the July 15, 2026 transaction date. The activity was executed through the conversion of 40,000 options at $19.26 and $23.06 per share, which were... Full story
Yahoo Finance • last month
A Corcept Director Holds 1.5 Million Shares Through a 50% Crash and Rebound
Key Points The transaction involved the sale of 10,000 shares at $88.30 per share, resulting in a total value of $883,000 on July 15, 2026. The sale reduced the insider's total indirect equity holdings by 0.67%. These shares were held ind... Full story
Yahoo Finance • last month
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?
Comparing First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) and iShares Biotechnology ETF (NASDAQ:IBB) reveals a choice between FBT's highly concentrated portfolio and IBB's broader, market-cap-weighted industry exposure. Both... Full story
Yahoo Finance • last month
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook
William Guyer, chief development officer, reported a sale of 20,000 shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) on July 7, 2026, according to an SEC Form 4 filing. Transaction summary Metric Value Transaction value $1.9 mil... Full story
Yahoo Finance • 2 months ago
Alger Russell Innovation Index Updates for Second Quarter 2026
NEW YORK, June 25, 2026 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the close... Full story
Yahoo Finance • 2 months ago
Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm
NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Corcept Therapeutics Incorporated (NASDAQ: CORT) breached their fiduciary duties t... Full story
Yahoo Finance • 2 months ago
Top Growth Companies With Insider Ownership In June 2026
Over the last 7 days, the United States market has experienced a 3.3% decline, yet it remains up by 22% over the past year with earnings anticipated to grow by 17% annually in the coming years. In this context, growth companies with substa... Full story
Yahoo Finance • 3 months ago
3 Growth Stocks With High Insider Ownership And 29% Revenue Growth
Over the last 7 days, the United States market has experienced a 2.7% drop, yet it has risen by 23% over the past year with earnings expected to grow by 17% annually. In this context, growth stocks with high insider ownership can offer uni... Full story
Yahoo Finance • 3 months ago
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech
Key Points Invesco Pharmaceuticals ETF has a significantly lower five-year maximum drawdown and lower volatility profile than State Street SPDR S&P Biotech ETF State Street SPDR S&P Biotech ETF offers a more diversified approach with 151... Full story
Yahoo Finance • 3 months ago
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?
The State Street SPDR S&P Pharmaceuticals ETF(NYSEMKT:XPH) offers a lower-cost entry into the drug manufacturing space, while the First Trust NYSE Arca Biotechnology Index Fund(NYSEMKT:FBT) provides concentrated exposure to biotechnology.... Full story
Yahoo Finance • 3 months ago
Spotlight On AppLovin And 2 More Growth Stocks With Significant Insider Stakes
The United States market has shown robust performance, climbing 1.2% in the last week and rising 27% over the past year, with earnings projected to grow by 17% annually in the coming years. In such a thriving environment, growth companies... Full story